Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7197296 | 1.00 | F2 (0.69) | F2MEN1KMT2AHSD17B3NPC1 | |
| SCHEMBL29367779 | 0.91 | F2 (0.60) | F2NPC1RAB9A | |
| SCHEMBL7187176 | 0.91 | F2 (0.60) | F2NPC1RAB9A | |
| SCHEMBL7198317 | 0.91 | F2 (0.63) | F2MEN1KMT2ANPC1RAB9A | |
| Methyl Alcohol SCHEMBL28295371 | 0.90 | F2 (0.58) | F2NPC1RAB9A | |
| SCHEMBL7194539 | 0.83 | MEN1 (0.55) | F2MEN1KMT2AHSD17B3NPC1 | |
| SCHEMBL4841064 | 0.83 | POLB (0.62) | F2MEN1KMT2A | |
| SCHEMBL4316064 | 0.82 | POLB (0.70) | F2NPC1RAB9A | |
| SCHEMBL31237171 | 0.82 | POLB (0.70) | F2NPC1RAB9A | |
| SCHEMBL435484 | 0.81 | F2 (0.49) | F2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119386005-A | Use of compounds for the production of a medicament for the treatment and/or prophylaxis of diseases which are associated with inhibition of PDE2 activity | 常州大学 | 2025-02-07 | — | — | CN | disclosed |